Lymphoma Clinical Trials in Dallas, Texas

3 studies are recruiting for lymphoma in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

    Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor k…

    Stage
    Phase 1
    Ages
    Up to 25
    Site
    The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas, Texas
    Locations
    68 in total
    Run by
    Turning Point Therapeutics, Inc.

    See if you can join NCT04094610 on ClinicalTrials.gov

  2. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: * Advanced, which means cancer spread in the body or cannot be removed with surgery * Relapsed, which means cancer has come back …

    Stage
    Phase 1
    Ages
    0 to 17
    Site
    Call for Information (Investigational Site 0054), Dallas, Texas
    Locations
    16 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT02332668 on ClinicalTrials.gov

  3. T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

    This is an open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety of an autologous T-cell therapy (EB103) and to determine the Recommended Phase II Dose (RP2D) in adult subjects (≥ 18 years of age) who have relapsed/refractory (R/R) B-cell NHL. The study will incl…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Baylor Scott & White Research Institute, Texas Oncology, Dallas, Texas
    Locations
    2 in total
    Run by
    Estrella Biopharma, Inc.

    See if you can join NCT06343311 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.